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Abstract. G2-arrested oocytes contain cdc2 kinase as
an inactive cyclin B-cdc2 complex . When a small
amount of highly purified and active cdc2 kinase, pre-
pared from starfish oocytes at first meiotic metaphase,
is microinjected into Renopus oocytes, it induces acti-
vation of the inactive endogenous complex and, as a
consequence, drives the recipient oocytes into M phase.
In contrast, the microinjected kinase undergoes rapid
inactivation in starfish oocytes, which remain arrested
at G2 . Endogenous cdc2 kinase becomes activated in
both nucleated and enucleated starfish oocytes injected
with cytoplasm taken from maturing oocytes at the
time of nuclear envelope breakdown, but only
cytoplasm taken from nucleated oocytes becomes able
thereafter to release second recipient oocytes from
G2 arrest, and thus contains M phase-promoting fac-
tor (MPF) activity. Both nucleated and enucleated
starfish oocytes produce MPF activity when type 2A
C
EJ.r.s in M phase contain a dominant factor, called
M phase-promoting factor (MPF)' which is able
upon transfer to drive G2 cells into M phase (Masui
and Markert, 1971; Kishimoto et al., 1982) or to induce
prematurely some cytological features of M phase in G,
cells (Johnson and Rao, 1970). Purification of MPF activity
from vertebrate and .invertebrate oocytes at meiotic meta-
phase led to isolation ofa single active component, identified
as cdc2 kinase, a stoichiometric complex between cyclin B
and cdc2. It corresponds to the major M phase-specific H,
histone kinase, not only in oocytes and early embryos, but
also in yeast (reviewed in Nurse, 1990; Dor6e, l99Ó). Possi-
bly, cdc2 kinase is not the single component with MPF activ-
ity in intact cells, for several reasons. Firstly, reducing con-
ditions are required to preserve enzymatic activities during
fractionation, which could conceivably separate associated
proteins from the cyclin B-cdc2 complex (Meikrantz et al.,
1991). Secondly, factors sharing MPF activity in common
with cdc2 kinase may undergo inactivation during homoge-
nization or fractionation of cell extracts. In agreement with
this view, at leastone component with MPF activity could be
1. Abbreviation used in this paper: MPF, M phase-promoting factor.
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phosphatase is blocked by okadaic acid. If type 2A
phosphatase is only partially inhibited, neither
nucleated nor enucleated oocytes produce MPF activ-
ity, although both do so if purified cdc2 kinase is sub-
sequently injected as a primer to activate the en-
dogenous kinase. The nucleus of starfish oocytes
contains an inhibitor of type 2A phosphatase, but nei-
ther active nor inactive cdc2 kinase. Microinjection of
the content of a nucleus into the cytoplasm of G2-
arrested starfish oocytes activates endogenous cdc2
kinase, produces MPF activity, and drives the recipi-
ent oocytes into M phase. Together, these results show
that the MPF amplification loop is controlled, both
positively and negatively, by cdc2 kinase and type 2A
phosphatase, respectively. Activation of the MPF am-
plification loop in starfish requires a nuclear compo-
nent to inhibit type 2A phosphatase in cytoplasm.
separated from cdc2 kinase when homogenates were treated
with adenosine. (3'-O-thio)-triphosphate (ySATP), to pro-
duce thiophosphorylated proteins resistant to phosphatases
(Dorde et al., 1989; Yamashita and Maller, 1990; Kuang et
al. 1991). EfficiencyofySATPtreatment was enhanced when
part ofprotein phosphatase activity was removed by ammo-
nium sulfate precipitation as the first step of MPF purifica-
tion (Hermann et al., 1983; Cyert and Kirschner, 1988).
Nonetheless, biochemical identification of MPF as cdc2
kinase is satisfactory, because genetic analysis did not dem-
onstrate any cell cycle control gene acting downstream of
cdc2+, which appears to control ultimately the G2 to M
phase transition in fission yeast (see Nurse, 1990 for review).
Furthermore, addition of active cdc2 kinase to extracts pre-
pared from interphase cells has been shown to trigger many
mitotic events, including the shortening of centrosome-
nucleated microtubules, associated with an increased turn-
over oftubulin in microtubules (Verde et al ., 1990), and the
inhibition of intracellular membrane fusion (Thomikoski et
al., 1989). Finally, cdc2 kinase has been shown to phos-
phorylate mitosis-specific sites on lamins B (Peter et al.,
1990a), vimentin (Chou et al., 1990), nonmuscle caldesmon
(Yamashito et al., 1991), nucleolar proteins (Peter et al.,
3371990b; Belenguer et al ., 1990), and H, histone (Langan et
al ., 1989) . Thereby, cdc2 kinase plays a key role atMphase
in disassembly ofboth thelamina andthe remainingnetwork
of intermediate filaments, alteration in the organization of
the microfilament cytoskeleton, disassembly of the nucleo-
lus, and chromosome condensation .
However, there is a more characteristic property ofMPF,
noteasily accessible to either genetical or biochemicalanal-
ysis . MPFwas initially defined as a factor in maturing oo-
cytes which, upon microinjection, can drive a G2-arrested
oocyte into M phase. Serial transfer in which the recipient
of atransfer becomes the donorofthe next one remains suc-
cessful even in the absence of protein synthesis (Wasserman
and Masui, 1975 ; Dome, 1982 ; Gerhart et al ., 1984). This
property is referred to as MPF amplification.
In this work, we began to dissect the MPF amplification
loop . More specifically, we investigated whethermicroinjec-
tion of a smallamount ofcdc2 kinase is sufficient to produce
more cdc2 kinase activity in recipient oocytes. This was
found to hold true in Xenopus, but not starfish oocytes . In
the latter case, a factor sequestered in the germinal vesicle
(GV), the large nucleus ofG 2-arrested oocytes, was found
to be required for cdc2 kinase activation . It could be
bypassed by specific inhibition of type 2A phosphatase, sug-
gesting that cdc2 kinase and an unidentified inhibitor of type
2A phosphatase act synergistically to induce MPF am-
plification.
MaterialsandMethods
Oocytes, Enucleations, and Microinjections
ThestarfishesAstropectenaranciacus and Marthasteriasglacialis were col-
lected during the breeding season near Banyuls, France . Prophase-arrested
oocytes were prepared free of follicle cells by washing them several times
in artificial Cal'-free sea water and finally transferred to natural sea water .
Xenopus oocytes were prepared freeoffolliclecells either by manual dissec-
tion with forceps or collagenase treatment . We performed enucleations as
previously described (Picard et al ., 1988a) by sucking the germinal vesicle
into a micropipette. Microinjections were performed according to Hira-
moto (1974) .
Cdc2 Kinase Preparation
Starfishcdc2 kinase (thecyclinB-cdc2 heterodimer) was prepared to appar-
ent homogeneity asreportedpreviously (Labbe et al ., 1989a, 1991) . Briefly,
an homogenate was prepared from oocytes at first meioticmetaphase. The
high-speed supernatantwas passed throughaDEAE-cellulose column and
eluted at 200mM NaCl . The eluate was applied to acolumn of Sepharose
covalently bound to the yeast protein pl3suc l . After washing the column,
the kinase was eluted with p13I" in excess. The eluted kinase was applied
on aMono Scolumn, and eluted at 330mM NaCl . Its specific activity was
N8 Amol of phosphate transferred to Hl histone perminute per milligram
of proteins .
H t Histone Kinase Activities
Assays of purified H, histone kinase were performed as previously de-
scribed(LabM et al ., 1989a, 1991). Assays of H1 histone kinase in oocytes
was as follows : microinjected oocytes were rapidly washed (<10 s) in an
excess ofbuffer containing 50mM R-glycerophosphate, 15 mM EGTA, 10
MM MgC12, and0.7 mM DTT at pH 7.3 ; then the oocyyts were taken in
a smallvolume of buffer (2 Al for starfish oocytes, 50 Al forXenopus oo-
cytes) and frozen in liquid nitrogen . Immediately after thawing, which dis-
rupted the oocytes, an identical volume of a mixture containing 40 mM
Hepes, pH 7.3, 10 mM MgC12, 100 AM 7-32P-ATP (103 cpm/pmol) and2
mg/ml H1 histone (Boehringer, Mannheim, Germany) was added. After
various incubation times (from 0 to 10 min) at 23°C, the reaction was
stoppedby additionofLaemmli'sbuffer, then the proteins were separatedby
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SDS-PAGE . Autoradiography wasperformed on dried gels withX-OMATS
films (Eastman KodakCo., Rochester, NY), then parts of the gels were cut
and counted by liquid scintillation . Theamount of cdc2 kinase that cata-
lyzes the transfer of 1 picomol of phosphate from ATPto H, histone per
minute was taken as unit.
Immunoblotting
After electrophoresis, proteins were transferred to nitrocellulose mem-
branes (Schleicher&Schuell, Keene, NH). Before incubation with affinity-
purified polyclonal antibodies raised in rabbits against bacterially produced
cyclin B(LaWet al ., 1989a) oragainsttheEGVPSTAIREISLLKE peptide
(PSTAIR), a sequence conserved in cdc2 homologues, blots were treated
with Tris-buffered saline (25mM Tris,pH7.5,200mM NaCl, 1mM CaC12,
5MM MgC12) containing 3% polyvinylpyrrolidone and0.05% Tween20.
After antibody binding, the blots were washed; a second antibody directed
against rabbit immunoglobulins and conjugated with alkaline phosphatase
was then added . The blots were washed again and transferred in alkaline
phosphatase buffer (100 mM Tris, pH 9.5, 100mM NaCl, 5 MM M9Cl2
containing 66 Al ofnitroblue tetrazolium and66 Al 5-bromo-4-chloro-3 in-
dolylphosphate for20 ml of buffer) . The staining reaction was stopped in
25 mM Tris, pH 7.5, 200mM NaCl, 1 mM EDTA .
Phosphatase Activities
[32p]Casein was prepared by incubating casein (0.2 mg) with the catalytic
subunit of cAMP-dependent protein kinase from rabbit skeletal muscle
(Beavo et al ., 1974) for4 h at 25°C in 100 Al of a solution containing 40
mM Hepes, pH 7.4, 10MM MgC12 , 1 mM DTT, and 100 AM ATP (2,000
cpm/pmol) . After incubation the mixture was extensively dialyzed over-
night at 4°C against 50 mM Tris, pH 7.0, 150 mM NaCl, 1 mM EDTA,
and 1 mM DTT .
Homogenates were prepared by freezing and thawing from 30 oocytes
(packed volume, x+0.2 Al) in 8 Al ofthe above buffer. To each homogenate
was added 5 Al of the [32p]casein solution, and incubation wasallowed to
proceed at room temperature for various times (from0 to 20 min) . Reac-
tions were stopped by adding 1 vol of 2% SDS. Then proteins were sepa-
rated by SDS-PAGE . Autoradiography was performed on dried gels .
Inhibitor 1 was an active thiophosphorylated peptide of inhibitor 1
(residues 9-41) prepared according to Aitken and Cohen (1982) . Okadaic
acid was dissolved in dimethylsulfoxide to give a 5mM solution, and fur-
ther diluted in aqueous buffer before use .
Results
Cdc2 Kinase Microinjection Is Sufficient
to Activate a Preformed CyclinB-cdc2 Complex
in Xenopus ButNot Starfish Oocytes
Cdc2 kinase was purified from starfish oocytes at first
meiotic metaphase . It contained two polypeptides, cor-
Figure 1 . Changes of Hl his-
tone kinase activities in recip-
ient oocytes after microinjec-
tion of various amounts of
purified cdc2 kinase. The up-
per panel refers to Xenopus
oocytes, theloweroneto star-
fishoocytes . H, histonekinase
activities, expressed as pico-
moles ofPtransferredpermin-
uteper microliter ofcytoplasm
(oocytevolumes were taken as 1 Al forXenopusand 8n1 forAstro-
pecten), were measured from 5-10 individual oocytes foreach ex-
periment . Homogenates were prepared from individual oocytes ei-
ther 10-15 s after microinjection (n) or 45 min (starfish) and 2 h
(Xenopus) later (o) . In control experiment (no cdc2 kinase in-
jected), HI histone kinase activities were measured in homoge-
nates prepared before hormonal stimulation (®) or at the time of
GVBD after hormonal stimulation (o).
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responding to intact cyclin B and p34cdc2 (Labbé et al.,
1989a) . Its MPF activity was tested by microinjection of 50
nl ofsolution into Xenopus oocytes (internal volume, til pl) .
We found that an activity of 10 U/p .I in the pipette was
sufficient to promote germinal vesicle breakdown (GVBD),
which occurred after cdc2 kinase activity had raised to -10
U/pl in the recipient oocytes (Fig . 1) . The same result was
obtained whether or not protein synthesis occurred in the re-
cipient oocytes, implying that amplification of histone Hl ki-
nase entailed activation of preformed (but inactive) cdc2 ki-
nase . In confirmation of this, we isolated the inactive cyclin
B-p34c&2 complex from G2-arrested oocytes and found that
the concentration of p34cdc2 and cyclin B was the same in
unactivated and activated oocytes (data not shown ; see also
Gautier and Mailer, 1991) . Together, these results show that
microinjection of active cdc2 kinase in Xenopus oocytes is
sufficient to activate an amplification loop that promotes the
conversion of an inactive cyclin B-p34°dc2 complex into its
active form (Fig. 2) .
By contrast, oocytes of the starfish Astropecten aranci-
acus did not undergo GVBD when the same preparation of
purified cdc2 kinase was delivered to their cytoplasm by
Figure 3 . Cdc2 kinase induces the G2 toM phase transition when
microinjected into the GV, but not the cytoplasm of starfish oo-
cytes . Oocyte A was microinjected with 1.5 nl of cdc2 kinase into
the cytoplasm, oocyte B was microinjected with 0.4 nl ofthe same
kinase preparation into the GV . Micrographs were taken immedi-
ately after microinjections (A t , B t), and 75 min (B2) and 2 h after
microinjection (A2), respectively . Bar, 100 jm .
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microinjection (Fig . 3 A), although like the frog oocytes,
they contained a preformed cyclin B-p34clc2 inactive com-
plex (Strausfeld et al ., 1991) . Even high amounts of the
purified cdc2 kinase, corresponding to about one halfthe to-
tal amount that would be formed upon hormonal oocyte acti-
vation, did not causeGVBD (Fig . 1), whereas direct transfer
ofone-tenth that amount (in terms ofhistone Hl kinase activ-
ity) of crude cytoplasm taken at the time ofGVBD caused
rapid GVBD in the recipient oocytes. We considered that the
important difference was the admixture in the latter case of
components from the germinal vesicle. To confirm this view,
enucleated oocytes were stimulated by transfer of cytoplasm
taken at the time of GVBD from hormone-stimulated oo-
cytes . As expected, cdc2 kinase activation occurred in recip-
ient oocytes (Fig . 4, sequence A,AS) . In contrast, neither
cdc2 kinase activation nor GVBD occurred in second recipi-
ent oocytes when they received cytoplasm taken from enu-
cleated oocytes (Fig . 4, E,-E2) . Finally GVBD occurred
and endogenous kinase was activated when oocytes received
a small amount of the purified cdc2 kinase directly into the
GV (Fig . 3 B) . Together, the above results show that microin-
jection in the cytoplasm ofnative cdc2 kinase is not sufficient
to activate the amplification loop in starfish oocytes, and
suggest that its mixing with a nuclear factor originating from
theGV is required to protect it from rapid inactivation upon
transfer in G2-arrested oocytes . Since ["S]methionine-la-
beled starfish cyclin B does not undergo proteolysis when
microinjected into starfish oocytes (data not shown), cdc2
kinase inactivation is not due to degradation of its cyclin B
subunit . Possible mechanisms of inactivation include phos-
phorylation on inhibitory sites and dephosphorylation of
stimulating sites on either the cdc2 or the cyclin B subunits
(see Discussion) .
Inhibition ofType 2A PhosphataseMimics the
Nuclear FactorRequiredfor Microinjected cdc2Kinase
to Release Starfish Oocytesfrom G2 Arrest
There are several indications that serine-threonine phospha-
tases play an important part in maintaining the G2 arrest of
oocytes . For example Lee et al . (1991) showed that INH, an
inhibitor of MPF activation in Xenopus, corresponds to a
type 2A . phosphatase . Moreover, okadaic acid (OA), the
powerful inhibitor of protein phosphatases types 1 and 2A
obtained from dinoflagellates (see Cohen et al ., 1990, for re-
view) promotes oocyte maturation in several animal species
(Goris et al ., 1989 ; Rime and Ozon, 1990) . This suggested
that perhaps the component from the germinal vesicle might
be a type 2A phosphatase inhibitor.
In starfish, OA induces MPF activation when injected to
an intracellular concentration of 1-2 AM . This high concen-
tration is required to titrate type 2A phosphatase, which is
in the micromolar range in starfish oocytes (Picard et al.,
1989) . As a first test of the above hypothesis, we tried inject-
ing purified cdc2 kinase into oocytes in the presence of low
doses of akadaic acid . Indeed, we found that 0.3 p.M OA
potentiatedGVBD in response to cdc2 kinase (Fig . 5) . This
potentiation could be overcome by microinjection of the
catalytic subunit of type 2A phosphatase (data not shown),
and could not be mimicked by inhibitors 1 and 2, which
block the activity of type 1 phosphatase (Table I) .
To test the idea that theGV contained an inhibitor of type
2A phosphatase, casein was phosphorylated by A kinase and
339Figure 4. MPF amplification in a recipient oocyte requires a nuclear factor transferred with the donorcytoplasm. Oocyte AZwas obtained
by enucleating oocyte A, . 20 min after enucleation (A3) it received cytoplasm, taken 30 min afterhormonal stimulation from a maturing
oocyte (B). 30 min after the first cytoplasm transfer, cytoplasmwas taken from the first recipient, now used as donor (A4) and transferred
into the cytoplasm of an intact oocyte (E,), which remained arrested at GZ even 2 h later (E2) . When the same sequence of experiments
was made using anucleated oocyte as first recipient (D,, DZ), GVBD readily occurred in the second recipient (F Z) 20 min after cytoplasm
transfer, shown in F, . In each panel, the inset shows H, histone activity (estimated by the darkness of theH, histone spot from autoradio-
grams andthe corresponding number of eluted counts perminute : see Materials and Methods) . AS is amagnification ofA4 ; it shows that
transfer ofcytoplasm taken from the maturing oocyte B has induced, not only H, histone kinase activation, but also the nucleation ofun-
usually big meiotic asters (arrowheads) . Bar, 200 i4m .
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340Figure S . Microinjection of
cdc2 kinase induces the G2-
to-M phase transition only if
recipient starfish oocytes have
been previously microinjected
with an infraliminar amount
(0.3 uM) of okadaic acid . Oo-
cytes a, b, d, e, g, and h were
microinjected with 50 pl of50
ttMOA(final intracellularcon-
centration, -0.3 p,M) . Oo-
cytes b, c, e, f, h, and i were
then microinjected with 0.4 nl
of cdc2 kinase, purified to ap-
parenthomogeneity (100pmol
of P transferred to H, histone
per minute per microliter) .
Micrographs were taken 2 h
after the last microinjection :
only oocytes b, e, and h have
been released from G 2 arrest.
Bar, 200 ,um .
used as a substrate to compare the phosphatase activities of
homogenates of enucleated and intact starfish oocytes. De-
phosphorylation of casein was completely inhibited by 3 nM
OA, and not significantly by 100 nM inhibitor 1 in diluted
homogenates . Therefore, it was due almost exclusively to
type2A phosphatase, as previously reported (Cormier et al . ,
1990) . As expected, the phosphatase activity of the enucle-
ated oocytes was reproducibly higher than that of intact
oocytes (Fig . 6) . Nonetheless, no inhibition of type2A phos-
phatase could be detected when the GV contents were di-
rectly assayed on purified type 2A phosphatase (data not
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Table I. Coinjection ofInhibitor 1 and 2Does Not Help
cdc2 Kinase to Release Starfish Oocytesfrom G2 Arrest
Number of recipient oocytes
with GVBD
Coinjected compounds
(all 0.3 aM)
￿
Number of injected oocytes
None
￿
0/10
Okadaic acid
￿
10/10
Inhibitor 1
￿
0/10
Inhibitor 2
￿
0/10
Inhibitor 1 plus inhibitor 2
￿
0/10
G 2-arrested oocytes ofthe starfish Astropecten aranciacus were injected, first
with each phosphatase inhibitor to the indicated intracellular concentration,
then (5 min later) with 0.4 nl of cdc2 kinase (specific activity: 10 picomol P
transferred to Hl histone perminute per microliter) . Oocytes with GVBD were
scored 1 h later (percentages did not change subsequently) .
shown), suggesting that the GV may only indirectly exert a
negative control on the activity of type 2A phosphatase .
We next tested whether microinjection ofthe content ofthe
GV could induce oocyte maturation by itself, and it did (Fig.
7) . In this experiment, cdc2 kinase activity was stimulated
-20-fold in the recipient oocyte (Table 1I), although theGV
does not contain any detectable H, histone kinase activity
(data not shown), lacks cyclin B, and contains only a faint
amount of cdc2 (Fig . 8) . Moreover, such activation could be
blocked by the simultaneous injection of p13-t (Table II),
which is well known to block the activation of cdc2 kinase
(Dunphy and Newport, 1989) . Thus, oocyte activation ap-
pears to require the activation of cdc2 kinase, and the germi-
nal vesicle contains an essential component of the amplifi-
cation loop, which perhaps negatively controls type 2A
phosphatase activity.
Discussion
The MPF amplification process is currently viewed as a
regulatory loop of posttranslational events by which a low
amount ofmicroinjected cdc2 kinase acts as a primer, result-
ing in production of more cdc2 kinase from an inactive en-
dogenous pool in G 2-arrested oocytes . In agreement with
this view, we found that microinjection ofactive cdc2 kinase,
prepared to apparent homogeneity from starfish oocytes, is
sufficient to activate the MPF amplification loop in Xenopus
oocytes .
Nonetheless, cdc2 kinase failed to drive the inactive cyclin
B-cdc2 precursor into its active form when microinjected
Figure 6. Type 2A phospha-
tase activity is higher in
extracts prepared from enucle-
ated than from nucleated oo
cytes . Phosphatase activities were compared by monitoring the
amount of residual [32p]casein on autoradiograms after incubating
for 20 min at 25°C extracts prepared from 30 oocytes, nucleated
or enucleated, in the presence of [ 32P]casein (see Materials and
Methods) . A, nucleated oocytes ; B, enucleated oocytes ; C enucle-
ated oocytes plus 100 nM inhibitor 1; D, enucleated oocytes plus
3 nM okadaic acid ; E, the amount of [32P]casein added at zero
time in each of the above experiments was run on the same gel
(control) .
34 1Figure 7 . Microinjection of the content ofone germinal vesicle in-
duces the G2-to-M phase transition in recipient oocytes . (A) The
content of a GV is being sucked from a donor oocyte (d) . (B) It
is being microinjected into the cytoplasm (near theGV in this ex-
periment, but this is not necessary for successful transfer) of a re-
cipient oocyte (r) . (C)1 h laterGVBD hadoccurred in the recipient
oocyte. Bar, 200 jum .
into oocytes of the starfish Astropecten aranciacus . Rather,
the injected kinase underwent rapid inactivation in recipient
oocytes . This suggests that another component exerts a nega-
tive control and may neutralize the priming effect of injected
cdc2 kinase .
Why does purified cdc2 kinase undergo inactivation when
it is microinjected into G2-arrested starfish oocytes? As al-
ready emphasized, it is not due to degradation of its cyclin
B subunit . It is also unlikely that cyclin dephosphorylation
could be sufficient to inactivate cdc2 kinase, since extensive
activation can be triggered in extracts prepared from G2-
arrested amphibian or starfish oocytes-which contain the
dephosphorylated form of cyclin-either by depleting ATP
Figure 8. CyclinB is localized exclusively in the cytoplasm ofG2 -
arrested starfish oocytes, and only a faint amount of cdc2 is in the
GV. Western blots were made from 10 intact oocytes (lanesA and
F), 10 enucleated oocytes (lanes B and E) or 60 whole GV (lanes
C and D) using polyclonal antiserums directed against starfish cy-
clin B, or a 16-amino acid peptide corresponding to the PSTAIR
domain of p34cdc2 . The arrowhead points to p34~'°2 on the PSTAIR
immunoblot .
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Table IL Microinjection ofthe Content ofa GVIs Su fficient
to Activate cdc2 Kinase and to Release Starfish Oocytes
from G2 Arrest
Microinjected material
￿
to
Cdc2 kinase activity"
t5o GVBD
GV alone
￿
15 t 6
￿
330 t 70
￿
10/10
GV plus p13 1- 1 ￿16 1 5
￿
18 f 9
￿
0/10
G2-arrested oocytes were injected either with the content of a single GV
alone, or with both aGV and 10 AM p13'°°' . H, histone kinase activities were
measured in homogenates prepared from individual oocytes, either before or
50 min after microinjections . GVBD occurred earlier than 50 min after
microinjection of GV material alone . It never occurred when p13'-' was
coinjected . Cdc2 kinase activities are expressed as femtomoles ofP transferred
to H, histone per minute per oocyte (each result obtained from 10 oocytes) .
(Labbd et al., 1988a, b, 19896) or by adding phosphatases
of broad specificity in the absence of ATP (Jessus et al .,
1990 ; Pondaven et al., 1990) . Furthermore, in the absence
of ATP, the mitotic inducer cdc25+ readily activates the cy-
clin B-cdc2 complex prepared from G2-arrested oocytes
(Kumagai and Dunphy, 1991 ; Strausfeld et al ., 1991) . There-
fore, inactivation is most likely due to rephosphorylation of
the microinjected kinase on inhibitory sites of its cdc2
subunit (Labbé et al ., 19896 ; Gautier et al ., 1989 ; Dunphy
and Newport, 1989 ; Morla et al ., 1989 ; Picard et al ., 1989 ;
Gould and Nurse, 1989), and inhibition of type2A phospha-
tase antagonizes this process in the cytoplasm of G2 -
arrested oocytes.
The inhibitory kinases that phosphorylate cdc2 have not
been identified in oocytes, but there is genetic evidence in
fission yeast that at least two protein kinases negatively con-
trol cdc2 kinase activity. One is p107-, which is able to
phosphorylate both tyrosine and serine/threonine residues, at
least in vitro (Featherstone and Russel, 1991) . The other is
pmikl, whose specificity is not known (Lundgren et al .,
1991) . The weel+ gene product, at least, is negatively con-
trolled by another protein kinase, pNm' . Interestingly, mu-
tants inppa2, a gene which encodes a homologue oftype2A
phosphatase, have the same phenotype as mutants in weel+
and mikl+ and enter M phase at a reduced size (Kinoshita
et al ., 1990) . This supports the view that type 2A phospha-
tase antagonizes protein kinases, whose function is to cancel
the inhibitory effect of p107-' and pmik' on cdc2 kinase ac-
tivity. If such a network of inhibitory controls exists in G2-
arrested oocytes, it could explain why partial inhibition of
type 2A phosphatase potentiates GVBD in response to cdc2
kinase microinjection, and why complete inhibition of type
2A phosphatase is sufficient to induce GVBD in the absence
of any other treatment . The alternative hypothesis that inhi-
bition of type2A phosphatase might increase the activity of
a putative cdc2 phosphatase (Dorde et al ., 1989) is now un-
likely, since the unphosphorylated cdc25+ gene product ap-
pears sufficient to induce cdc2 dephosphorylation and acti-
vation, at least in vitro (Strausfeld et al ., 1991) .
Several years ago, we proposed that an unidentified factor
originating from theGV was required in addition to cdc2 ki-
nase for production of transferable MPF activity in starfish
oocytes (Picard et al ., 19886 ; see also Kishimoto et al .,
1981 ; Picard and Dorde, 1984) . Indeed, we had found that
cdc2 kinase reaches its maximal activity after hormonal
stimulation well before cytoplasm becomes able to induce
342GVBD in recipient oocytes (Labbd et al ., 1987). Moreover,
cytoplasm taken from stimulated enucleated oocytes was
found to lack transferable MPF activity, although they pro-
duced as much cdc2 kinase activity as nucleated oocytes.
More recently, we showed that enucleated oocytes can pro-
duce MPF activity upon hormonal stimulation if type 2A
phosphatase is partially depressed (by about one-third) by
microinjecting 0.3,uM OA . In fact, MPF activity is produced
even in the absence of hormonal stimulation in enucleated
oocytes if they receive a dose of OA sufficientto titrate com-
pletely type 2A phosphatase (Dorée et al ., 1991). Since
blocking type 1 phosphatase only with both inhibitor 1 or
2 had no such effect, the above experiments demonstrated
that specific inhibition of type 2A phosphatase suppresses
the requirement for the GV component in the process of
MPF amplification. In agreement with this view, we found
in the present work that partial inhibition of type 2A phos-
phatase in recipient oocytes potentiates GVBD in response
to cdc2 kinase, as does its admixture with components of
the GV.
The active component of the GV has not yet been
identified. We found, however, that type 2A phosphatase ac-
tivity is higher in homogenates made from enucleated than
from nucleated oocytes. Moreover, microinjection ofGV ma-
terial activates by itself cdc2 kinase in starfish oocytes, as
does that of 1 uM OA . This may indicate that the GV con-
tains an element that interacts physically with type 2A phos-
phatase to depress its activity. Alternatively the GV may only
indirectly control type 2A phosphatase activity via a loop of
as yet unidentified regulatory events. Whatever the explana-
tion, the inhibitory element would shuttle in the cytoplasm
before GVBD since cytoplasm becomes able to induce
GVBD in recipient oocytes just before the first cytological
marks of nuclear envelope disorganization ("GV fading") in
donor oocytes. We should notice that the GV component
would have escaped detection if its translocation had oc-
curred before hormonal stimulation. Perhaps such a translo-
cation occurs earlier in species like Xenopus, which can pro-
duce MPF in the absence of GV (Smith and Ecker, 1969;
Dabauvalle et al., 1988) . Removal of the GV has also been
shown to delay or to suppress appearance of transferable
MPF activity afterhormonal stimulation in two different am-
phibian species (Gautier, 1987; Skoblina et al., 1984) sug-
gesting that a requirement for a GV component in the process
of MPF amplification is not restricted to starfish oocytes.
Identification of this GV component will be a major step in
understanding the amplification loop for MPF amplification.
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